Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry S Wolinsky

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
The Lancet. Neurology|July 10, 2003
Rational therapy for relapsing multiple sclerosisJerry S Wolinsky
Advances in Neurology|January 13, 2006
The use of glatiramer acetate in the treatment of multiple sclerosisJerry S Wolinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Patient selection for trialsJerry S Wolinsky
Journal of the Neurological Sciences|February 1, 2003
The diagnosis of primary progressive multiple sclerosisJerry S Wolinsky,
Neurology|October 16, 2009
MRI lesion loads and disability relationships in MS: more similar than different?Jerry S Wolinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
The PROMiSe trial: baseline data review and progress reportJerry S Wolinsky,
Expert Opinion on Pharmacotherapy|April 23, 2004
Glatiramer acetate for the treatment of multiple sclerosisJerry S Wolinsky
Current Opinion in Neurology|June 5, 2002
Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brainJerry S Wolinsky, Ponnada A Narayana
The Lancet. Neurology|February 21, 2006
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled studyMassimo Filippi, Jerry S Wolinsky, Giancarlo Comi, et al.
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisXavier Montalban, Shibeshih Belachew, Jerry S Wolinsky
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
The Lancet. Neurology|July 10, 2003
Rational therapy for relapsing multiple sclerosisJerry S Wolinsky
Advances in Neurology|January 13, 2006
The use of glatiramer acetate in the treatment of multiple sclerosisJerry S Wolinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Patient selection for trialsJerry S Wolinsky
Journal of the Neurological Sciences|February 1, 2003
The diagnosis of primary progressive multiple sclerosisJerry S Wolinsky,
Neurology|October 16, 2009
MRI lesion loads and disability relationships in MS: more similar than different?Jerry S Wolinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
The PROMiSe trial: baseline data review and progress reportJerry S Wolinsky,
Expert Opinion on Pharmacotherapy|April 23, 2004
Glatiramer acetate for the treatment of multiple sclerosisJerry S Wolinsky
Current Opinion in Neurology|June 5, 2002
Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brainJerry S Wolinsky, Ponnada A Narayana
The Lancet. Neurology|February 21, 2006
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled studyMassimo Filippi, Jerry S Wolinsky, Giancarlo Comi, et al.
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisXavier Montalban, Shibeshih Belachew, Jerry S Wolinsky
Pageof 14